Trevi Therapeutics Announces First Quarter 2019 Financial Results and Recent Business Developments
June 13, 2019 16:09 ET
|
Trevi Therapeutics
Raised $70 Million in Gross Proceeds from Initial Public Offering and Concurrent Private Placement Initiated Phase 2 Clinical Trial for Chronic Cough in Patients with Idiopathic Pulmonary Fibrosis...
Algernon Pharmaceuticals Expands Its Research Program to Include Idiopathic Pulmonary Fibrosis
February 25, 2019 07:00 ET
|
Algernon Pharmaceuticals
VANCOUVER, British Columbia, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: BTHCF) (the “Company” or “Algernon”) a clinical stage pharmaceutical...
FibroGen Announces Publication of Phase 2 Study Results Supporting the Potential of FG-3019 to Treat Patients With Idiopathic Pulmonary Fibrosis
March 11, 2016 08:00 ET
|
FibroGen, Inc.
SAN FRANCISCO, March 11, 2016 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ:FGEN) (FibroGen) announced today that the European Respiratory Journal (“ERJ”) published on-line a manuscript...
Coalition for Pulmonary Fibrosis to Cease Operations
November 19, 2015 10:25 ET
|
Coalition for Pulmonary Fibrosis (CPF)
CULVER CITY, Calif., Nov. 19, 2015 (GLOBE NEWSWIRE) -- "Never doubt that a small group of thoughtful, committed, citizens can change the world. Indeed, it is the only thing that ever has." -- Margaret...
SPORTS RADIO HOST, COMMERCIAL BANK VP, ST. JUDE, UTHSC DOCTORS, TEMPLE ISRAEL RABBI TO SPEAK AT BOTANIC GARDEN CEREMONY
July 16, 2015 14:29 ET
|
Coalition for Pulmonary Fibrosis (CPF)
MEMPHIS, Tenn., July 16, 2015 (GLOBE NEWSWIRE) -- A deadly lung disease most have never heard of is lurking in the community and threatening the lives of some well-known Memphians as it has claimed...
CPF Celebrates Historic Year of Progress in Pulmonary Fibrosis
December 30, 2014 14:05 ET
|
Coalition for Pulmonary Fibrosis (CPF)
CULVER CITY, Calif., Dec. 30, 2014 (GLOBE NEWSWIRE) -- The Coalition for Pulmonary Fibrosis (CPF) played an important role in much of the year's successes in Pulmonary Fibrosis (PF), helping to make...
CORRECTION - Two FDA Approvals on Same Day Renew Hope for Pulmonary Fibrosis Community
October 16, 2014 17:19 ET
|
Coalition for Pulmonary Fibrosis (CPF)
CULVER CITY, CALIF., Oct. 16, 2014 (GLOBE NEWSWIRE) -- In its press release dated October 16, 2014 at 10:46 AM EST with the headline "Two FDA Approvals on Same Day Renew Hope for Pulmonary Fibrosis...
Two FDA Approvals on Same Day Renew Hope for Pulmonary Fibrosis Community
October 16, 2014 10:46 ET
|
Coalition for Pulmonary Fibrosis (CPF)
CULVER CITY, CALIF., Oct. 16, 2014 (GLOBE NEWSWIRE) -- Patients, families and researchers alike have anticipated for months the U.S. Food and Drug Administration (FDA) decisions on two drugs for...
CPF Applauds Two FDA Approvals Announced Today for First Drugs for Idiopathic Pulmonary Fibrosis
October 15, 2014 18:02 ET
|
Coalition for Pulmonary Fibrosis (CPF)
CULVER CITY, CALIF., Oct. 15, 2014 (GLOBE NEWSWIRE) -- The Coalition for Pulmonary Fibrosis (CPF) applauds the two U.S. Food and Drug Administration (FDA) approvals announced today for Idiopathic...
Pulmonary Fibrosis Patients, Families Take Center Stage at FDA
September 29, 2014 15:25 ET
|
Coalition for Pulmonary Fibrosis (CPF)
CULVER CITY, Calif., Sept. 29, 2014 (GLOBE NEWSWIRE) -- Most FDA panels involve high-level executives and renowned medical professionals in their given areas of expertise. On Friday, however, patients...